Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2024-07-23

FDA Approved: RECTIV — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for RECTIV (nitroglycerin) from Allergan, Inc., resulting in a label change.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RECTIV (nitroglycerin)

Snippet

SUPPL AP for RECTIV (NITROGLYCERIN)